Table 5.
Laboratory results of the entire cohort at a patient’s first clinic visit (only untreated patients)
| Risk factor |
With CVD |
Without CVD |
P-value |
|---|---|---|---|
| N = 74 | N = 221 | ||
| Total cholesterol (mmol/L) |
8.2(1.8) |
9.1(2.1) |
<0.001 |
| Mean (SD) | |||
| HDL cholesterol (mmol/L) |
1.2(0.3) |
1.4(0.4) |
0.001 |
| Mean (SD) | |||
| LDL-cholesterol (mmol/L) |
6.1(1.8) |
7.0(1.9) |
<0.001 |
| Mean (SD) | |||
| Triglycerides (mmol/L) |
1.7(0.9) |
1.7(1.2) |
0.968 |
| Mean (SD) | |||
| TC/HDL |
7.5(3.5) |
7.3(2.8) |
0.684 |
| Mean (SD) |
|
|
|
| Lp (a) (mg/L)* |
331.5 |
278.8 |
0.480 |
| Median (IQR) |
(111.2,691.6) |
(102.6,569.7) |
|
| Fasting blood sugar (mmol/L) |
5.4(0.6) |
5.1(0.5) |
0.001 |
| Mean (SD) | |||
| Lipid lowering therapy (%) | 0.0 | 0.0 | NA |